title: [Face necrotizing fasciitis following spinocellular epithelioma excision].
abstract: Necrotizing fasciitis is a bacterial dermo-hypodermitis with superficial aponevrosis necrosis due to Streptococcus pyogenes. Head and neck region are some rare localization of this infection especially after surgery. We report herein a case of a face necrotizing fasciitis following minor face surgery. A 86 year-old Caucasian male without any antecedents, nor treatment, has been operated for a fronthead spinocellular epithelioma under local anesthesia. Twelve hours later, a severe pain localized to the face occurred, with sleeplessness, followed up with a face orbitary oedema and fever. Twenty-four hours later, an intravenous antibiotherapy was therefore started and surgical treatment was performed as soon as the diagnosis of necrotizing fasciitis was considered. An important inflammatory oedema was noticed, associated to a large necrotic softening of the face, the eyelid and the neck sub-cutaneous tissues. Then, the patient has been transferred in intensive care unit because multi-organ failure clinical and biological signs occurred. Pre-operatory bacteriological samples culture identified Streptococcus pyogenes. Repeated surgical explorations and debridement (excision, cleaning, draining and bandages recovery) were performed daily as needed until all the necrotic tissue was all eradicated. The antibiotherapy was prescribed to totalised 15 days. Our report underlines the importance of an early recognition of the diagnosis of soft tissue infection, because early surgical treatment has a better prognosis and antibiotic treatment alone is inefficient for the recovery. Alert is delivered by the local signs quickly followed up by skin changes. Anti-inflammatory therapy must be avoid in case of any soft tissue infection sign: they may increase the lesions, hide alarm signs and delay surgical treatment.
authors.affiliation: Département d'anesthésie et réanimation, hôpital Saint-Roch, 5, rue Pierre-Devoluy, BP 1319, 06006 Nice cedex 01, France. stephanegindre@wanadoo.fr
authors.forename: S
authors.initials: S
authors.lastname: Gindre
authors.forename: J
authors.initials: J
authors.lastname: Dellamonica
authors.forename: E
authors.initials: E
authors.lastname: Couadau
authors.forename: M
authors.initials: M
authors.lastname: Carles
authors.forename: F
authors.initials: F
authors.lastname: Vandenbos
authors.forename: P
authors.initials: P
authors.lastname: Delgiudice
authors.forename: D
authors.initials: D
authors.lastname: Grimaud
authors.forename: C
authors.initials: C
authors.lastname: Ichai
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002277:Carcinoma / Q000601:surgery*; D004487:Edema / Q000209:etiology; D019115:Fasciitis, Necrotizing / Q000188:drug therapy / Q000209:etiology* / Q000601:surgery*; D006801:Humans; D007249:Inflammation / Q000209:etiology; D008297:Male; D011183:Postoperative Complications / Q000188:drug therapy / Q000209:etiology* / Q000601:surgery*; D011379:Prognosis; D012878:Skin Neoplasms / Q000601:surgery*; D013297:Streptococcus pyogenes / Q000302:isolation & purification* / Q000472:pathogenicity; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents